Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides

Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides

US Patent 11111506 · Granted Sep 7, 2021

Estimated economic value: $51,979,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid encoding reactions2024
CRISPR-associated (Cas) protein2024
CRISPR-associated (Cas) protein2024
Multi-primer amplification method for barcoding of target nucleic acids2023
Engineered nucleic acid-targeting nucleic acids2022
Engineered nucleic acid-targeting nucleic acids2022
Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides2022
Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides2022
Compositions and methods of nucleic acid-targeting nucleic acids2022
Compositions and methods of nucleic acid-targeting nucleic acids2022
CRISPR-associated (CAS) protein2022
CRISPR hybrid DNA/RNA polynucleotides and methods of use2022